Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finances

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Aug 13, 2024 5:33am

170 Views

Post# 36175929

RE:RE:RE:RE:RE:RE:Finances

That was absolutely the most important statement in the NR, 3rd quarter, but then again we have heard that before but im feeling this time it may be different, some had mentioned we might have reapplied pre BTD, could be the case and that was what they were waiting for so they got the recent results to the FDA

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project